Claude models lead early drug discovery challenge against GPT-4

VIDRAFT has launched the Open Discovery Challenge, a drug discovery competition hosted on Hugging Face, where participants use various AI models to propose candidate molecules for malaria and tuberculosis. Early data from the first three days shows that submissions using Claude-family models outperformed those using OpenAI-family models on both disease tracks. This generative benchmark differs from traditional ones by evaluating AI-assisted molecule generation rather than prediction accuracy, aiming to accelerate research for neglected diseases. AI

IMPACT Suggests potential advantages of certain LLMs in scientific research and drug discovery, influencing future model development and application.

RANK_REASON This item reports on early benchmark data for AI models in a drug discovery context, which falls under research. [lever_c_demoted from research: ic=1 ai=1.0]

Read on dev.to — LLM tag →

• Anthropic
• ChatGPT
• Claude
• DeepSeek
• Gemini
• GPT-4
• Hugging Face
• malaria
• OpenAI
• Open Discovery Challenge
• Qwen
• tuberculosis
• VIDRAFT

• product
• model release
• other

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →